Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.

1 Nov 2021

BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers

A new study has been published in Vaccines that evaluated the effectiveness of Cominarty against documented SARS-CoV-2 infection and symptomatic diseases in the medium to long term.

1 Nov 2021

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

A new review discusses how molecular and structural biology have contributed to our understanding of antibody recognition of HIV-1, SARS-CoV-2, and Zika.

1 Nov 2021

Study finds inhaled microspheres reduce SARS-CoV-2 infective effectiveness

A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.

1 Nov 2021

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Study suggests increased pediatric COVID-19 hospitalizations related to increased Delta variant incidence

The current study compares the severity of the illness in children infected by the wild-type strain compared with the VOC now prevalent in terms of outcomes in this age group.

1 Nov 2021

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.

1 Nov 2021

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

A recent study published in the journal Cellular & Molecular Immunology shows that a new A.30 variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can evade vaccine-induced antibodies and might spread outside the lungs extraordinarily well, with important implications for our public health response.

1 Nov 2021

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is one of the most important ways of fighting the ongoing COVID-19 pandemic, the recommendations for vaccination for pregnant and breastfeeding women are not consistent.

1 Nov 2021

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

A new study demonstrates the influence of prior infectious outbreaks in a large population on succeeding pandemic outcomes.

31 Oct 2021

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

A new study explores the role of new SARS-CoV-2 variants in sustaining the pandemic in South Africa.

31 Oct 2021

New Canadian serology solution for SARS-CoV-2 infections and vaccination

A new study developed a “Made-in-Canada” solution for enabling scalable and reproducible SARS-CoV-2 serology.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

20 million more Oxford-AstraZeneca vaccines donated to COVAX

A further ten million Oxford-AstraZeneca vaccines have been sent by the UK to COVAX, with 10 million more due to be delivered in the coming weeks to some of the world's most vulnerable people.

30 Oct 2021

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

The National Institute on Aging of the National Institutes of Health has awarded researchers at Washington University School of Medicine in St. Louis a five-year, $9.1 million grant to study resilience in older adults before and during the COVID-19 pandemic, as well as the pandemic's cognitive and emotional effects on older adults.

30 Oct 2021

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

University of Utah Health scientists are on the leading edge of a pair of large studies investigating the long-term effects of COVID-19.

30 Oct 2021

Opening schools for in-person learning not linked with increase in COVID-19 case rates

Since March 2020, parents, educators, and politicians have debated whether to send children to school in person during the COVID-19 pandemic.

30 Oct 2021

Children and adults have similar risks of SARS-CoV-2 infection, but kids do not show symptoms

New research addresses the misconception that children are less susceptible to infection with the new coronavirus.

30 Oct 2021

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

University of Utah Health scientists are leading an effort to determine if salivary glands infected with the virus that causes COVID-19 could diminish a person’s long-term immunity to the disease after being immunized or after recovering from the illness.

30 Oct 2021

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

When the delta variant of the coronavirus hit the Sierra Conservation Center — a low- to medium-security prison for men in California — residents who had received the Moderna vaccine were well protected against symptomatic infection, according to Stanford-led research.

30 Oct 2021

Pandemic News and Research

Further Reading

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

Study finds inhaled microspheres reduce SARS-CoV-2 infective effectiveness

Factors predicting cognitive symptoms in long COVID

Study suggests increased pediatric COVID-19 hospitalizations related to increased Delta variant incidence

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Pregnant and breastfeeding women's perceptions and concerns about COVID-19 vaccines

Areas with higher 1968 influenza pandemic mortality have lower COVID-19 deaths

The impact of SARS-CoV-2 variants on the COVID-19 epidemic in South Africa

New Canadian serology solution for SARS-CoV-2 infections and vaccination

The ability of natural flavonoids to inhibit SARS-CoV-2

20 million more Oxford-AstraZeneca vaccines donated to COVAX

Researchers receive $9.1 million grant to study resilience in older adults before and during the pandemic

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

Opening schools for in-person learning not linked with increase in COVID-19 case rates

Children and adults have similar risks of SARS-CoV-2 infection, but kids do not show symptoms

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

Moderna vaccine offers substantial protection against delta variant in vaccinated prisoners

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News